News | August 30, 2024
Ayurvedic Whole System effective in Managing Rheumatoid Arthritis: Study
The study highlighted substantial improvements in key clinical parameters among RA patients who underwent AWS intervention
The study highlighted substantial improvements in key clinical parameters among RA patients who underwent AWS intervention
PiaSky advances C5 inhibition through innovative recycling technology, which enables its monthly SC administration
In a Phase 3 trial, Pfizer and BioNTech’s combination vaccine candidate against influenza and COVID-19 met one of its two primary immunogenicity objectives
These results add to the growing body of evidence indicating a single dose of ABRYSVO provides strong immune protection against outcomes caused by RSV
CN201 is a next generation CD3xCD19 bispecific antibody that augments and diversifies Merck’s pipeline, with potential applications in B-cell malignancies and autoimmune diseases
Boehringer Ingelheim aims to develop this program as a potential key centerpiece component for its immuno-oncology portfolio
Decision on EU marketing authorisation for this population expected by September 2024
Leqselvi delivered statistically significant efficacy across two Phase 3 clinical trials
Doxorubicin Hydrochloride Liposome Injection (RLD Doxil) had estimated annual sales of USD 42 million in the U.S. (IQVIA MAT May 2024)
Acquisition to expand Lilly's immunology pipeline with oral integrin therapies
Subscribe To Our Newsletter & Stay Updated
